Genitourinary cancer patients have worse baseline semen parameters than healthy sperm bankers
- PMID: 30786173
- DOI: 10.1111/andr.12602
Genitourinary cancer patients have worse baseline semen parameters than healthy sperm bankers
Abstract
Background: While the spermatotoxic properties of cancer treatments such as chemotherapy and radiation therapy are widely recognized, the effect of malignancy itself on male fertility is not clearly understood.
Objectives: To determine whether malignancy is associated with diminished semen quality prior to spermatotoxic treatment among sperm bankers.
Materials and methods: Retrospective database review of de-identified records was obtained for all episodes of sperm banking performed at a cryobank from January 2004 to May 2017 for one of the following reasons: 'future use' (e.g., military deployment and gender reassignment); infertility; benign disease; and malignancy, further categorized as testicular, other genitourinary (GU), solid non-GU, hematologic, or unspecified. Dependent variables of interest were ejaculatory volume, sperm concentration, % motility, and total motile sperm count (TMSC), as well as post-thaw TMSC.
Results: A total of 1558 patients met the inclusion criteria. Multivariable regression analysis on log-transformed data controlling for age demonstrated decreased ejaculatory volume and sperm concentration, % motility, and TMSC in the infertility group as compared to the 'future use' group (p < 0.001). Testicular cancer was associated with decreased sperm concentration, TMSC, and post-thaw TMSC (p < 0.001); other GU malignancy was associated with decreased ejaculatory volume (p < 0.001). Benign disease, solid non-GU malignancy, hematologic malignancy, and unspecified malignancy were not associated with decreased parameters.
Discussion: In addition to sperm bankers with known fertility issues, sperm bankers with testicular and other GU malignancy had worse baseline semen parameters as compared to individuals pursuing banking for future use. These findings can inform patient counseling and consent prior to sperm banking and disease treatment.
Conclusion: Individuals with testicular and other GU malignancy who banked spermatozoa before undergoing spermatotoxic therapy demonstrated worse baseline semen parameters as compared to individuals banking spermatozoa for non-medical reasons.
Keywords: cryopreservation; malignancy; semen analysis; sperm banks; spermatozoa.
© 2019 American Society of Andrology and European Academy of Andrology.
Similar articles
-
Sperm cryopreservation of transgender individuals: trends and findings in the past decade.Andrology. 2018 Nov;6(6):860-864. doi: 10.1111/andr.12527. Epub 2018 Aug 9. Andrology. 2018. PMID: 30094956 Free PMC article.
-
Sperm banking for fertility preservation: a 20-year experience.Eur J Obstet Gynecol Reprod Biol. 2013 Sep;170(1):177-82. doi: 10.1016/j.ejogrb.2013.06.021. Epub 2013 Jul 16. Eur J Obstet Gynecol Reprod Biol. 2013. PMID: 23870186
-
Effect of cryopreservation on semen quality in patients with testicular cancer.Urology. 1995 Sep;46(3):382-9. doi: 10.1016/s0090-4295(99)80224-6. Urology. 1995. PMID: 7660514
-
Semen quality in men with malignant diseases before and after therapy and the role of cryopreservation.Eur Urol. 2007 Aug;52(2):355-67. doi: 10.1016/j.eururo.2007.03.085. Epub 2007 Apr 5. Eur Urol. 2007. PMID: 17498866 Review.
-
Fertility managment in testicular cancer: the need to establish a standardized and evidence-based patient-centric pathway.BJU Int. 2019 Jan;123(1):160-172. doi: 10.1111/bju.14455. Epub 2018 Jul 27. BJU Int. 2019. PMID: 29920910 Review.
Cited by
-
Identifying the Need to Discuss Infertility Concerns Affecting Testicular Cancer Patients: An Evaluation (INDICATE Study).Cancers (Basel). 2021 Feb 1;13(3):553. doi: 10.3390/cancers13030553. Cancers (Basel). 2021. PMID: 33535586 Free PMC article.
-
Recent Publication Trends in Radiotherapy and Male Infertility over Two Decades: A Scientometric Analysis.Front Cell Dev Biol. 2022 May 12;10:877079. doi: 10.3389/fcell.2022.877079. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35646894 Free PMC article.
-
Testicular cancer survivorship: Long-term toxicity and management.Can Urol Assoc J. 2022 Aug;16(8):257-272. doi: 10.5489/cuaj.8009. Can Urol Assoc J. 2022. PMID: 35905486 Free PMC article. Review. No abstract available.
-
SARS-CoV-2 pandemic and repercussions for male infertility patients: A proposal for the individualized provision of andrological services.Andrology. 2021 Jan;9(1):10-18. doi: 10.1111/andr.12809. Epub 2020 May 22. Andrology. 2021. PMID: 32357288 Free PMC article.
-
Effect of Malignancy on Semen Parameters.Life (Basel). 2022 Jun 20;12(6):922. doi: 10.3390/life12060922. Life (Basel). 2022. PMID: 35743953 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous